An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
Coronavirus infection 2019 is considered a modern challenge to the world community. In the absence of vaccines and antivirals, effective and safe medicines are an urgent request from the healthcare system. We have evaluated the medical technologies for COVID-19 which are being examined. The search w...
Guardado en:
Autor principal: | A. S. Kolbin |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01eb08e21d814ff0b0dfa1aee6ed1e0c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
por: Alina Kröker, et al.
Publicado: (2021) -
A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
por: A. Abayomi, et al.
Publicado: (2021) -
Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
por: Qomara WF, et al.
Publicado: (2021) -
Antiviral Combination Clinically Better Than Standard Therapy in Severe but Not in Non-Severe COVID-19
por: Panda PK, et al.
Publicado: (2021) -
Some opportunities for immunotherapy in coronavirus infection
por: V. S. Smirnov, et al.
Publicado: (2020)